Publications by authors named "Nikolay V Conev"

Claim this Profile
H
Histone-based liquid biopsy discriminates between myelodysplastic syndrome and solid malignancies.
Desislava K Tsoneva, Diana Buzova, Salvatore Daniele Bianco, Ilina Micheva, Merlin Efraim, Nikolay Vladimirov Conev

Clin Epigenetics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time estimation is associated with the levels of distress in patients prior to starting radiotherapy.
Kiril Zh Zhelev, Nikolay V Conev, Zahari I Zahariev, Iglika S Mihaylova, Ivan D Tonev

Tech Innov Patient Support Radiat Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of translationally controlled tumor protein in colon cancer.
Dragomir Svetozarov Stoyanov, Nikolay Vladimirov Conev, Mariya Ivanova Penkova-Ivanova, Ivan Shterev Donev

Mol Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Histones to Detect and Monitor the Progression of Cancer.
Desislava K Tsoneva, Martin N Ivanov, Nikolay Vladimirov Conev, Rostislav Manev, Dragomir Svetozarov Stoyanov

Int J Mol Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of travel burden on clinical outcomes in lung cancer.
Dragomir Svetozarov Stoyanov, Nikolay Vladimirov Conev, Ivan Shterev Donev, Ivan Dimitrov Tonev, Teodorika Vitalinova Panayotova

Support Care Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
Yuanbin Chen, Luis Paz-Ares, Niels Reinmuth, Marina Chiara Garassino, Galina Statsenko, Nikolay V Conev

JTO Clin Res Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Jonathan W Goldman, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Nikolay V Conev

Lancet Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast time perception is associated with high levels of anxiety in cancer patients prior to starting chemotherapy.
Ivan Shterev Donev, Martina Stoyanova Ivanova, Nikolay Vladimirov Conev

Biosci Trends· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Mila P Petrova, Mariyana I Eneva, Jeliazko I Arabadjiev, Nikolay V Conev, Eleonora G Dimitrova

Biosci Trends· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Nikolay V Conev

Lancet· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-minute time interval estimation as a novel ultrashort tool for distress screening.
Nikolay Vladimirov Conev, Ivan Shterev Donev, Dragomir Svetozarov Stoyanov

Support Care Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer.
Nikolay V Conev, Eleonora G Dimitrova, Margarita K Bogdanova, Yavor K Kashlov, Borislav G Chaushev

Clin Invest Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the pretreatment F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression.
Eleonora G Dimitrova, Borislav G Chaushev, Nikolay V Conev, Javor K Kashlov, Aleksandar K Zlatarov

Biosci Trends· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of RIPK3 and troponin I as potential biomarkers for predicting impaired left ventricular function in patients with myocardial infarction with ST segment elevation and normal troponin I levels prior percutaneous coronary intervention.
Javor K Kashlov, Ivan S Donev, Jordanka G Doneva, Veselin D Valkov, Arpine D Kirkorova, Nikolay V Conev

Biosci Trends· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum expression levels of miR-17, miR-21, and miR-92 as potential biomarkers for recurrence after adjuvant chemotherapy in colon cancer patients.
Nikolay V Conev, Ivan S Donev, Assia A Konsoulova-Kirova, Trifon G Chervenkov, Javor K Kashlov

Biosci Trends· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Adenoid Cystic Carcinoma of the Skin with Multiple Local Recurrences.
Ivan Dimitrov Tonev, Yana Stoeva Pirgova, Nikolay Vladimirov Conev

Case Rep Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis